Timothy Dean Garon (September 13, 1951 – May 1, 2008) was an American singer/songwriter who was denied a liver transplant by the University of Washington Medical Center due to his legal use of cannabis.
Garon contracted the hepatitis C virus (HCV) and received medical cannabis under the supervision of a physician in compliance with Initiative 692 of the State of Washington's Medical Use of Marijuana Act of 1998. The law makes it legal for patients to use, possess and cultivate cannabis with a medical certificate according to state law, but not according to U.S. federal law. [1] Garon's physician "authorized Garon to smoke pot to alleviate nausea and abdominal pain and to stimulate his appetite." [2]
The issue raises ethical concerns regarding future transplants. The American Civil Liberties Union and the Marijuana Policy Project posted blogs on the internet addressing Garon's story.
Tim Garon recorded two albums: "Drunk in the Arms of Love" with Nashville producer/guitarist Cam King, and "Silence of Her Heart" with T-Bone Wolk of SNL fame and who played with Hall & Oates.
Medical cannabis, or medical marijuana (MMJ), is cannabis and cannabinoids that are prescribed by physicians for their patients. The use of cannabis as medicine has not been rigorously tested due to production and governmental restrictions, resulting in limited clinical research to define the safety and efficacy of using cannabis to treat diseases.
Proposition 215, or the Compassionate Use Act of 1996, is a California law permitting the use of medical cannabis despite marijuana's lack of the normal Food and Drug Administration testing for safety and efficacy. It was enacted, on November 5, 1996, by means of the initiative process, and passed with 5,382,915 (55.6%) votes in favor and 4,301,960 (44.4%) against.
Cedars-Sinai Medical Center is a non-profit, tertiary, 915-bed teaching hospital and multi-specialty academic health science center located in Los Angeles, California. Part of the Cedars-Sinai Health System, the hospital has a staff of over 2,000 physicians and 10,000 employees, supported by a team of 2,000 volunteers and more than 40 community groups. As of 2022–23, U.S. News & World Report ranked Cedars-Sinai among the top performing hospitals in the western United States. Cedars-Sinai is a teaching hospital affiliate of David Geffen School of Medicine at the University of California, Los Angeles (UCLA), which was ranked in the top 20 on the U.S. News 2023 Best Medical Schools: Research.
Seattle Hempfest is an annual event in the city of Seattle, Washington advocating the legalization of cannabis. Vivian McPeak serves as the organization's executive director. Founded in 1991 as the Washington Hemp Expo, a self-described "humble gathering of stoners" attended by only 500 people, and renamed the following year as Hempfest, it has grown into a three-day annual political rally, concert, and arts and crafts fair with attendance typically over 100,000. Speakers have included Seattle city council member Nick Licata, actor/activist Woody Harrelson (2004), travel writer and TV host Rick Steves (2007), (2010), 2012 Green Party speaker Jill Stein, Dallas Cowboys center Mark Stepnoski (2003), and former chief of the Seattle Police Department Norm Stamper (2006). Hempfest has also in recent years attracted such well-known performers as Fishbone (2002), The Kottonmouth Kings (2004), Rehab (2006), and Pato Banton (2007) to its five stages spread throughout Myrtle Edwards Park and Elliott Bay Park, on Seattle's waterfront.
In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act, the category reserved for drugs that have "no currently accepted medical use", is a proposed legal and administrative change in cannabis-related law at the federal level. After being proposed repeatedly since 1972, in 2024, the US Department of Justice announced it was initiating rulemaking to reschedule cannabis to Schedule III of the Controlled Substances Act.
Mary Jane Rathbun, popularly known as Brownie Mary, was an American medical cannabis rights activist. As a hospital volunteer at San Francisco General Hospital, she became known for baking and distributing cannabis brownies to AIDS patients. Along with activist Dennis Peron, Rathbun lobbied for the legalization of cannabis for medical use, and she helped pass San Francisco Proposition P (1991) and California Proposition 215 (1996) to achieve those goals. She also contributed to the establishment of the San Francisco Cannabis Buyers Club, the first medical cannabis dispensary in the United States.
In the United States, the non-medical use of cannabis is legalized in 24 states and decriminalized in 7 states, as of November 2023. Decriminalization refers to a policy of reduced penalties for cannabis offenses, typically involving a civil penalty for possessing small amounts, instead of criminal prosecution or the threat of arrest. In jurisdictions without penalty the policy is referred to as legalization, although the term decriminalization is sometimes used for this purpose as well.
In the United States, increased restrictions and labeling of cannabis as a poison began in many states from 1906 onward, and outright prohibitions began in the 1920s. By the mid-1930s cannabis was regulated as a drug in every state, including 35 states that adopted the Uniform State Narcotic Drug Act. The first national regulation was the Marihuana Tax Act of 1937.
Cannabis in Oregon is legal for both medical and recreational use. In recent decades, the U.S. state of Oregon has had a number of legislative, legal, and cultural events surrounding use of cannabis. Oregon was the first state to decriminalize the possession of small amounts of cannabis, and among the first to authorize its use for medical purposes. An attempt to recriminalize possession of small amounts of cannabis was turned down by Oregon voters in 1997.
In the United States, the use of cannabis for medical purposes is legal in 38 states, four out of five permanently inhabited U.S. territories, and the District of Columbia, as of March 2023. Ten other states have more restrictive laws limiting THC content, for the purpose of allowing access to products that are rich in cannabidiol (CBD), a non-psychoactive component of cannabis. There is significant variation in medical cannabis laws from state to state, including how it is produced and distributed, how it can be consumed, and what medical conditions it can be used for.
Cannabis in California has been legal for medical use since 1996, and for recreational use since late 2016. The state of California has been at the forefront of efforts to liberalize cannabis laws in the United States, beginning in 1972 with the nation's first ballot initiative attempting to legalize cannabis. Although it was unsuccessful, California would later become the first state to legalize medical cannabis through the Compassionate Use Act of 1996, which passed with 56% voter approval. In November 2016, California voters approved the Adult Use of Marijuana Act with 57% of the vote, which legalized the recreational use of cannabis.
Initiative 1068 was a proposed initiative for the November 2010 Washington state general election that would have removed criminal penalties from the adult use, possession, and cultivation of marijuana in Washington. Sponsored by Vivian McPeak, Douglass Hiatt, Jeffrey Steinborn, Philip Dawdy, initiative I-1068 sought to legalize marijuana by removing marijuana offenses from the state's controlled substances act, but failed to gather enough signatures to qualify for the ballot.
In the United States, cannabis is legal in 38 of 50 states for medical use and 24 states for recreational use. At the federal level, cannabis is classified as a Schedule I drug under the Controlled Substances Act, determined to have a high potential for abuse and no accepted medical use, prohibiting its use for any purpose. Despite this prohibition, federal law is generally not enforced against the possession, cultivation, or intrastate distribution of cannabis in states where such activity has been legalized. On May 1, 2024, the Associated Press reported on plans by the Drug Enforcement Administration to move marijuana to the less-restrictive Schedule III.
Washington Initiative 502 (I-502) "on marijuana reform" was an initiative to the Washington State Legislature, which appeared on the November 2012 general ballot, passing by a margin of approximately 56 to 44 percent. Originally submitted to the Washington Secretary of State during the summer of 2011, enough signatures were collected and submitted by December to meet the required 241,153 signatures, sending it to the legislature. When the legislature adjourned without action in April, Initiative 502 automatically advanced to the November 2012 general ballot. It was approved by popular vote on November 6, and took effect over the course of a year, beginning with certification no later than December 6, 2012. Along with a similar Colorado measure, Initiative 502 was credited for encouraging voter turnout of 81%, the highest in the nation.
Leafly is a website focused on cannabis use and education. The company says it has more than 120 million annual visitors and over 10 million monthly active users. Leafly provides a wide range of information on cannabis including 1.5 million consumer product reviews, more than 9,000 cannabis articles and resources, and over 5,000 verified strains in its database. Leafly additionally provides 4,500+ retailers and 8,000+ cannabis brands with e-commerce tools such as digital storefronts, embedded menus, point-of-sale integrations, targeted advertising, and more. The company is headquartered in Seattle, Washington and from 2012 to 2019 was owned by Privateer Holdings, a private equity firm focused on the emerging legal cannabis industry. Leafly is now a publicly traded company with 160 employees.
The legal history of cannabis in the United States began with state-level prohibition in the early 20th century, with the first major federal limitations occurring in 1937. Starting with Oregon in 1973, individual states began to liberalize cannabis laws through decriminalization. In 1996, California became the first state to legalize medical cannabis, sparking a trend that spread to a majority of states by 2016. In 2012, Washington and Colorado became the first states to legalize cannabis for recreational use.
Cannabis in Washington relates to a number of legislative, legal, and cultural events surrounding the use of cannabis. On December 6, 2012, Washington became the first U.S. state to legalize recreational use of marijuana and the first to allow recreational marijuana sales, alongside Colorado. The state had previously legalized medical marijuana in 1998. Under state law, cannabis is legal for medical purposes and for any purpose by adults over 21.
The possession, use, and distribution of cannabis without a license in the State of Israel are violations under the Dangerous Drugs Ordinance. A decade ago, despite these regulations, enforcement was relatively lax, partially influenced by a political movement advocating tolerance. Over the years, the enforcement approach has progressively become more lenient. As of 2021, cannabis use has been fully decriminalized, with it being treated as an administrative infraction primarily when used in highly visible public places. There is a possibility that cannabis may be legalized for recreational use by adults aged 21 and older in the future, with regulations akin to those for alcohol. Public and cross-party political support for the complete decriminalization of cannabis increased in the 2010s with increasing usage for both medical and recreational purposes, and the establishment of a political party primarily devoted to this cause; on July 19, 2018, the Knesset approved a bill for decriminalization, although the supporters of recreational cannabis use insisted that this did not represent complete decriminalization. The law came into effect on April 1, 2019. On June 25, 2020, further legislation designed to decriminalize possession of up to 50 grams of cannabis began its passage through the Knesset.
The Cannabis Act (C-45) of June, 2018 paved the way for the legalization of cannabis in Canada on 17 October 2018. Police and prosecution services in all Canadian jurisdictions are currently capable of pursuing criminal charges for cannabis marketing without a licence issued by Health Canada. The Supreme Court of Canada has held that the federal Parliament has the power to criminalize the possession of cannabis and that doing so does not infringe upon the Canadian Charter of Rights and Freedoms. The Ontario Court of Appeal and the Superior Court of Ontario have, however, held that the absence of a statutory provision for medical marijuana is unconstitutional, and to that extent the federal law is of no force and/or effect if a prescription is obtained. The recreational use of cannabis has been legalized by the federal government, and took effect on 17 October 2018.
Eaze is an American company based in San Francisco, California that launched a medical cannabis delivery app of the same name in 2014.